Inspire Medical (INSP): Market Cap to Revenue

Symbol and logo of brand Inspire Medical (INSP)

Inspire Medical Systems net profit is based on the global recognition of its safe systems for combating apnea. The price-to-sales trend clearly demonstrates the market valuation, where the value 2.00 reflects the current dynamics. High physician confidence confirms the brand's exclusivity, while the implementation of compact neurostimulators has created a high-tech alternative to masks, radically simplifying the treatment process.

INSP Inspire Medical P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Inspire Sleep (INSP)

- share price and consensus valuation forecast:
Price Performance Chart inspiresleep.com|INSP - Price Target Chart
- stock exchange capitalization data:
Market Valuation Inspire Sleep|INSP - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Inspire Medical Systems|INSP - Book Capitalization|Capitalization to Book Value Ratio inspiresleep.com|INSP - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Inspire Medical Systems|INSP - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Inspire Medical Systems Inc|INSP - Company Aggregate Debts|Debts to Book Capitalization Inspire Sleep|INSP - Company Long-Term Debt|Company Short-Term Debt Inspire Medical Systems|Intermediate Coverage Ratio inspiresleep.com
- earnings and multiples data:
INSP - Net Profit|Expected Net Profit Inspire Medical Systems|INSP - Price to Earnings Ratio|Forward Price to Earnings Multiple Inspire Medical|INSP - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Inspire Sleep|INSP - Operating profit EBITDA|Net earnings per share for the last four quarters Inspire Medical Systems|INSP - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months inspiresleep.com|INSP - Earnings per share growth in current year|Expected earnings per share growth for next year Inspire Medical Systems
- issuer revenue and sales details:
INSP - Revenue and Sales Volume|Company Expected Sales Volume inspiresleep.com|INSP - Price-to-Revenue Ratio|Market Cap to Projected Revenue Inspire Sleep
General company analysis:INSP inspiresleep.com
Core merchandise of Inspire Medical Systems

Analyzing the resilience of Inspire Medical Systems (INSP) to market downturns requires an assessment of the monetization efficiency of its innovative apnea treatment systems, which are scaled through a global network of medical centers. The dynamics of the company's price-to-sales ratio reflect the market value of a single dollar of revenue, allowing investors to determine whether the business is overvalued or if the asset is in an accumulation phase ahead of a new growth cycle.

Competitors of Inspire Medical Systems

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Procept|CNMD: P/S Multiple|Market Cap to Revenue Ratio PLSE|INMD (InMode) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack, Inc.|Market Cap to Revenue Ratio NAOV (nanovibronix.com)|Price-to-Revenue Ratio Venus Concept Corp (VERO)|Price-to-Revenue Coefficient Nuwellis Corp|Price-to-Revenue Ratio Aethlon Medical AEMD|ASXC (Asensus Surgical Inc) - Price-to-Sales Ratio|Avinger - P/S Multiple|Price-to-Revenue Coefficient BioSig BSGM|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|Price to Sales nevro.com NVRO|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio